A dated editorial feed of notable vaccine evidence, safety statements and policy developments. We link to the original source and distinguish new information from established evidence.
WHO and Africa CDC announced an initial allocation of 70,000 Ervebo doses to the Democratic Republic of the Congo. Importantly, WHO says it is not yet known whether Ervebo protects humans against Bundibugyo virus; 20,000 doses were allocated to a Phase 3 trial and 50,000 for frontline and health workers under current recommendations.
Read the WHO announcement →WHO's August 2026 position paper incorporates developments in typhoid disease burden and vaccination. This is the type of primary policy document ANTIVAX.co.uk will track when recommendations or evidence summaries change.
WHO Immunization, Vaccines and Biologicals →The UK medicines regulator said multiple large studies have found no evidence that vaccines cause autism in children. It also highlighted continuous surveillance through Yellow Card reports, healthcare datasets, international safety information and independent expert review.
Read the MHRA statement →The July 2026 position paper updates WHO recommendations in the context of continued SARS-CoV-2 circulation and population immunity. Our archive can use position papers like this to distinguish current recommendations from advice issued earlier in the pandemic.
WHO vaccine publications →WHO's current immunisation dashboard reports that 85% of infants received three DTP-containing vaccine doses in 2025, while an estimated 13.5 million children received no routine vaccination at all. Coverage data add important context to debates about access and hesitancy.
WHO immunisation data and updates →